Cybin (HELP) Treasury Shares (2021 - 2022)
Cybin's (HELP) quarterly Treasury Shares came in at $12.5 million in Q1 2022, down 57.81% YoY from $29.7 million in Q1 2021, and down 57.81% on a QoQ basis from $29.7 million in Q1 2021.
Cybin (HELP) Treasury Shares (2021 - 2022) Analysis & Trends
Cybin (HELP) has 2 years of Treasury Shares data on file, last reported at $12.5 million in Q1 2022.
- Quarterly Treasury Shares fell 57.81% year-over-year to $12.5 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $12.5 million (down 57.81% YoY) and the FY2022 annual result came in at $12.5 million, down 55.98% from the prior year.
- Treasury Shares fell to $12.5 million in Q1 2022, from $29.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $29.7 million in Q1 2021 to a low of $12.5 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 12.55 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Mar 31, 2021 | 29.74 Mn |
| Mar 31, 2021 | 29.74 Mn |